{"role": "assistant", "content": null, "function_call": {"name": "get_risks", "arguments": "{\"risks\":[{\"Description\":\"Increased exposure to pathogens in densely populated environments\",\"Impact\":\"Reduced well-being, health issues, and economic impact due to absenteeism and reduced productivity\",\"Mitigation\":\"Improved ventilation and air filtration, regular disinfection of surfaces, and promotion of personal hygiene\",\"Technologies\":\"HEPA filters, UV-C disinfection systems, and IoT-based monitoring systems\",\"People\":\"Population in densely populated environments\",\"Owner\":\"Building managers, public health authorities\"},{\"Description\":\"Rapid dissemination of new diseases and elevated risk of pandemics\",\"Impact\":\"Potential for widespread infection, high mortality rates, and economic disruption\",\"Mitigation\":\"Early detection systems, travel restrictions, and rapid response protocols\",\"Technologies\":\"Genomic surveillance, contact tracing apps, and AI-driven epidemiological models\",\"People\":\"Global population\",\"Owner\":\"Public health organizations, governments\"},{\"Description\":\"Rapid mutation of microorganisms and adaptation as a cause of human diseases\",\"Impact\":\"Potential for vaccine evasion, drug resistance, and increased transmission rates\",\"Mitigation\":\"Development of broad-spectrum antiviral drugs, global surveillance networks, and vaccine research\",\"Technologies\":\"CRISPR technology, big data analytics, and international collaboration platforms\",\"People\":\"Global population\",\"Owner\":\"Research institutions, pharmaceutical companies\"}]}"}}